The DOI matches its Crossref record; 71 of the 75 references it cites were found in a registry or an index; 12 of the 43 sources its claims cite were checked for support.
Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint
Open accessAbstract
: The medial collateral ligament (MCL) is one of the major supporting ligaments of the knee joint, and MCL injuries are common where excessive valgus loading is applied to the knee joint. Although most MCL injuries can be treated conservatively, healing of the MCL can take several weeks to months. Furthermore, once injured, the biomechanical properties of the healed MCL differ from those of the native MCL, resulting in an increased risk of re-injury and chronic remnant symptoms. Mesenchymal stem cells (MSCs), owing to their therapeutic potential, have been investigated in various musculoskeletal injuries, and some preclinical studies regarding MSC-based approaches in MCL injuries have shown promising results. Despite satisfactory results in preclinical studies, there is still a lack of clinical studies in the orthopedic literature. This article describes the basic knowledge of the MCL, standard treatments for MCL injuries, and recent studies regarding the application of MSCs for enhanced healing of the MCL. MSC-based approaches are expected to be a potential therapeutic option for enhanced healing of the MCL in the future.
Overview
CoChat Summary
TL;DR
This is a narrative review of medial collateral ligament (MCL) anatomy, biomechanics, standard treatment, and preclinical mesenchymal stem cell (MSC) approaches for enhanced healing. The paper concludes that MSC-based therapies look promising in animal studies, but clinical evidence is still lacking.
Key findings
- The MCL is described as the knee’s most frequently injured ligament, accounting for up to 40% of all knee ligament injuries and 7.9% of all knee injuries in a 10-year athletic study.
- The review identifies six preclinical studies of MSC use for MCL healing, and states that these studies have been conducted since 2002 in animal models only.
- Reported preclinical benefits included improved neovascularization, histology, and biomechanics; for example, in one rat study, CD34+ cells increased UEA-1+/HLA-ABC+ cells to 119.5 ± 20.0 vs 54.0 ± 16.5 in MNC and 0.0 ± 0.0 in controls, with capillary profiles of 301.0 ± 18.1 vs 209.5 ± 32.3 and 108.6 ± 15.6.
- The paper notes dose dependence in MSC effects: in one rat model, a low dose (1 × 10⁶ cells) produced better functional outcomes than a high dose (4 × 10⁶ cells), including increased failure strength and stiffness by day 14.
Methods
- Narrative review article synthesizing basic science, treatment, and preclinical literature on MCL injury and MSC-based healing.
- The paper’s own review found six studies of MSCs for MCL healing, all in preclinical animal model settings.
- Analysis is descriptive and chronological, summarizing reported anatomy, biomechanics, treatment approaches, and outcomes from the included studies.
Limitations
- The paper explicitly states that the literature is limited to preclinical animal studies, with a lack of clinical evidence.
- It also states that the precise mechanism by which MSCs enhance MCL healing is still unknown and that research on cell source, cell dosage, and reproducible preparation process is still in its infancy.
- Evident from the text: the review does not report a systematic search strategy or formal quality assessment of the included studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
10 Valid · 2 Not valid · 15 Not checked · 8 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Some preclinical studies regarding MSC-based approaches in MCL injuries have shown promising results.”
- Also stated in: § 8. Recent Research on MSC Applications for MCL Injury · plain
“As described above, there are several promising results in preclinical studies regarding the application of MSCs for the enhanced healing of MCL injuries.”
- Also stated in: § 9. Summary and Future Direction The MCL is one of the major ligaments supporting the knee joint and is the most commonly injured ligament [1,66,67]. Considering the neglected injuries and the recent increasing popularity of sports participation among both the general public and professional athletes, the frequency of MCL injuries might be much higher than expected. Although the MCL has a relatively good healing capacity, several studies have demonstrated that healing ligaments are less organized with decreased mechanical strength, leading to an increased risk of reinjury and poor functional outcome [68]. For this reason, there is a consistent need for new strategies to expedite the restoration of the injured MCL to its normal condition. Among the various recently employed therapeutic approaches, the use of MSCs for enhancing MCL healing has been highlighted because of their extensive proliferative ability, multi-differentiative potential, and reparative capacities. Although insufficient, recent preclinical studies have shown promising results in enhancing MCL healing using MSCs. However, only limited preclinical studies have been conducted, and the precise mechanism by which MSCs enhance MCL healing is still unknown. Research regarding the proper cell source, cell dosage, and reproducible preparation process is also still in its infancy. Therefore, further extensive investigations on MSCs are necessary to elucidate the fundamental cellular and molecular mechanisms, as well as to validate their safety and efficacy in clinical settings for enhanced MCL healing. · hedged
“Although insufficient, recent preclinical studies have shown promising results in enhancing MCL healing using MSCs.”
§ Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint > Abstract
What the sources say
- Supportedcites [60] Watanabe, 2002, Fate of donor bone marrow cells in medial collateral ligament after simulated autologous transplantation, Microsc. Res. Tech. source
The Discussion reports that bone-marrow cells containing MSCs survived in healing rat MCLs for 28 days and developed fibroblast-like morphology. It describes these findings as demonstrating the cells’ potential for ligament healing, supporting the citing sentence’s qualified description of promising preclinical results. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [61] Tei, 2008, Administrations of peripheral blood CD34-positive cells contribute to medial collateral ligament healing via vasculogenesis, Stem. Cells source
- Not checked — no full text of the sourcecites [62] Nishimori, 2012, Role of angiogenesis after muscle derived stem cell transplantation in injured medial collateral ligament, J. Orthop. Res. source
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § 8. Recent Research on MSC Applications for MCL Injury · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, mechanical tests demonstrated increased failure strength and stiffness in the low-dose group on day 14, suggesting that a lower dose of cells might be more effective in improving the functional properties of the injured MCL.”
§ Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint > 8. Recent Research on MSC Applications for MCL Injury
What the sources say
- Supportedcites [63] Saether, 2014, Enhanced medial collateral ligament healing using mesenchymal stem cells: Dosage effects on cellular response and cytokine profile, Stem. Cell. Rev. Rep. source
The Experimental Design section identifies a rat MCL injury model and day-14 mechanical testing. The Results (Mechanical Data) report significantly higher failure load and stiffness in low-dose MSC ligaments than in controls at day 14. The cited increase is relative to controls, not necessarily to the high-dose group. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, mechanical tests demonstrated increased failure strength and stiffness in the low-dose group on day 14, suggesting that a lower dose of cells might be more effective in improving the functional properties of the injured MCL.”
§ Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint > 8. Recent Research on MSC Applications for MCL Injury
What the sources say
- Supportedcites [63] Saether, 2014, Enhanced medial collateral ligament healing using mesenchymal stem cells: Dosage effects on cellular response and cytokine profile, Stem. Cell. Rev. Rep. source
The Results > Mechanical Data section reports higher failure load and stiffness at day 14 in low-dose MSC ligaments than in controls. The Discussion says the low dose improved functional mechanical outcomes and cautions that more MSCs is not necessarily better. The cited claim is appropriately hedged; the reported mechanical comparison is with controls, not a direct low-versus-high-dose test. (LLM, conf=0.94)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Increased early endothelization, a higher number of M2 macrophages, interleukin-1 receptor antagonists, and procollagen 1a levels were observed compared with other groups, suggesting a more anti-inflammatory environment in the MCL healing process.”
§ Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint > 8. Recent Research on MSC Applications for MCL Injury
What the sources say
- Supportedcites [65] Saether, 2016, Primed Mesenchymal Stem Cells Alter and Improve Rat Medial Collateral Ligament Healing, Stem. Cell. Rev. Rep. source
The Conclusion states that primed MSCs produced a less inflammatory healing environment, supported by increased M2 macrophages, IL-1Ra, early endothelialization, and procollagen 1α deposition. The Results (Immunohistochemistry) report higher early M2 levels and IL-1Ra in the primed-MSC group, although not every comparison with unprimed MSCs was statistically significant. Page numbers are not provided in our copy. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These studies have only been conducted in preclinical animal model settings since 2002.”
§ Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint > 8. Recent Research on MSC Applications for MCL Injury
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
8 more claims
Create a free account to see all 35 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 14
- The quote only partly states this claim. 1
Citations
Cites
Mesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992
In Search of the In Vivo Identity of Mesenchymal Stem Cells
da Silva Meirelles, L., Caplan, A. I., & Nardi, N. B. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1122 · Cited by 1,077
Epidemiology of athletic knee injuries: A 10-year study
Majewski, M., Susanne, H., & Klaus, S. (2006) · The Knee · doi:10.1016/j.knee.2006.01.005 · Cited by 935
The Anatomy of the Medial Part of the Knee
LaPrade, R. F., Ly, T. V., Wentorf, F. A., Engebretsen, A. H., Johansen, S., & Engebretsen, L. (2007) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200709000-00016 · Cited by 919 · cited 2×
“The meniscotibial ligament, which originates from the MM and attaches to the medial tibial plateau, is thicker and shorter [8].”
BackgroundThe effect of medial meniscectomy on anterior-posterior motion of the knee.
Levy, I. M., Torzilli, P. A., & Warren, R. F. (1982) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198264060-00011 · Cited by 801 · cited 1×
“It also acts as a secondary restraint to anterior tibial translation, particularly in anterior cruciate ligament (ACL)-deficient knees [11].”
BackgroundThe supporting structures and layers on the medial side of the knee: an anatomical analysis.
Warren, L. F., & Marshall, J. L. (1979) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-197961010-00011 · Cited by 678 · cited 2×
“5 cm distal to the joint line posterior to the pes anserinus [6,7].”
BackgroundThe supporting structures and layers on the medial side of the knee: an anatomical analysis.
Warren, L. F., & Marshall, J. L. (1979) · PubMed · Cited by 638
Grood, E. S., Noyes, F. R., Butler, D. L., & Suntay, W. J. (1981) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198163080-00007 · Cited by 546 · cited 1×
“It also provides approximately 57% of the restraining force against valgus stress during knee extension [12].”
BackgroundWoo, S. L., Gomez, M. A., Sites, T. J., Newton, P. O., Orlando, C. A., & Akeson, W. H. (1987) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198769080-00014 · Cited by 388
Medial collateral ligament healing: A multidisciplinary assessment in rabbits
Frank, C., Woo, S. L.-Y., Amiel, D., Harwood, F., Gomez, M., & Akeson, W. (1983) · The American Journal of Sports Medicine · doi:10.1177/036354658301100602 · Cited by 367 · cited 1×
“the affected joint and other structures in and around the knee joint are exposed to the risk of further damage [44,45].”
Background
Cited by
Georgiev, G. P., Gaydarski, L., & Landzhov, B. V. (2025) · Biomedicines · doi:10.3390/biomedicines13020522 · Cited by 8
Gaydarski, L., Landzhov, B. V., Tubbs, R. S., & Georgiev, G. P. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020510 · Cited by 3
“…studies further show that local delivery of CD34+ cells enhances MCL healing, primarily by promoting neovascularization and a pro-regenerative microenvironment [26–31]. α -SMA is an actin isoform that marks contractile cell phenotypes—vascular smooth muscle cells and myofibroblasts [32,33].”
Faus-Cotino, J., Andı́a, I., Lasarte, A. S., et al. (2026) · Orthopaedic Surgery · doi:10.1111/os.70394
Role of Orthobiologics in Knee Injuries
Alentorn‐Geli, E., García-Balletbó, M., & Cugat, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-58351-3_421
Role of Orthobiologics in Knee Injuries
Alentorn‐Geli, E., García-Balletbó, M., & Cugat, R. (2024) · Springer eBooks · doi:10.1007/978-3-642-36801-1_421-1
Metadata
- Authors
- Lee, C.-S., Jeon, O.-H., Han, S.-B., & Jang, K.-M.
- Affiliations
- Korea University (KR)
- Corresponding author
- Jang, Ki-Mo
- Venue
- Medicina
- Publisher
- MDPI AG
- Published
- 2023-04-07
- Volume
- 59
- Issue
- 4
- Pages
- 725
- ISSN
- 1010-660X (ISSN-L)
- 1648-9144
- PMC
- PMC10146272
- OpenAlex
- W4363675706
- Cited by
- 7
- References
- 75
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 2
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Medicina (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Trade, Industry & Energy (20003688)
- Topics
- Health Sciences › Medicine › Surgery › Knee injuries and reconstruction techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
- Keywords
- mesenchymal stem cells, medial collateral ligament, knee joint, ligament healing, valgus loading, stem cell therapy, ligament reconstruction
- MeSH terms
- Anterior Cruciate Ligament Injuries, Humans, Knee Joint, Wound Healing, Collateral Ligaments, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint. https://app.cochat.ai/papers/10.3390/medicina59040725
- The paper
- Lee, C.-S., Jeon, O.-H., Han, S.-B., & Jang, K.-M. (2023). Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint. Medicina. https://doi.org/10.3390/medicina59040725
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
